Pulmonary Hypertension (PH) with Heart Failure with preserved left ventricular ejection fraction (PH-HFpEF) research hub

A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Levosimendan in Pulmonary Hypertension Patients with Heart Failure with Preserved Left Ventricular Ejection Fraction

This study is testing a new medicine, levosimendan, for people with high blood pressure in their lungs and heart failure. It aims to see if the medicine helps them feel better and improves their walking distance.